Antibody response to tetanus, diphtheria, poliomyelitis, hepatitis B, and H. influenzae b vaccines in allogeneic hematopoietic stem cell transplant adult recipients: A multicenter trial.

Date publication

octobre 2025

Journal

PloS one

Auteurs

Membres identifiés du Cancéropôle Est :
Dr DAGUINDAU Etienne

Tous les auteurs :
Epaulard O, Carré M, Hermet E, Corbin V, Tavernier E, Botelho-Nevers E, Daguindau E, Brunel AS, Rohrlich PS, Risso K, Gallet S, Gonnet N, Touati S, Manceau M, Thiebault A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41144397

Résumé

National and international guidelines recommend vaccinating hematopoietic stem cell transplant (HSCT) recipients, although relatively few studies have evaluated immunogenicity in adults. We therefore aimed to assess the immune response in adult allogeneic HSCT recipients vaccinated against tetanus, diphtheria, poliomyelitis, hepatitis B, and H. influenzae b.

Mots clés

Humans, Hematopoietic Stem Cell Transplantation, Middle Aged, Male, Female, Hepatitis B Vaccines, immunology, Haemophilus Vaccines, immunology, Prospective Studies, Hepatitis B, prevention & control, Tetanus, prevention & control, Adult, Antibodies, Bacterial, blood, Poliomyelitis, prevention & control, Vaccination, Transplantation, Homologous, Antibody Formation, immunology, Diphtheria, prevention & control

Référence

PLoS One. 2025 10 27;20(10):e0335224